2023 marked the 10-year anniversary of the Institute of Medicine consensus report, Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis. The National Cancer Policy Forum and the American Society of Clinical Oncology co-hosted a workshop, Assessing and Advancing Progress in the Delivery of High-Quality Cancer Care, to provide an opportunity for the cancer community to gauge progress on implementation of the report recommendations and to discuss persistent challenges in achieving excellent and equitable cancer care. Workshop presentations and discussions considered additional actions that could be taken to improve progress, as well as aspects of cancer care that have changed over the past decade and thus might require new strategies to advance the delivery of high-quality cancer care.
Planning Committee
Patricia Ganz (Chair), University of California, Los Angeles Jonsson Comprehensive Cancer Center
Justin Bekelman, University of Pennsylvania Abramson Cancer Center
Narjust Florez, Dana-Farber Cancer Institute
Chris Friese, University of Michigan
Carolyn Hendricks, Maryland Oncology Hematology
Hedvig Hricak, Memorial Sloan Kettering Cancer Center
Larissa Nekhlyudov, Brigham & Women's Hospital and Dana-Farber Cancer Institute
Laurel Pracht, West Valley Ovarian Cancer Alliance
Nathan Pennell, Cleveland Clinic Cancer Center
Cardinale Smith, Mount Sinai Health System
Ishwaria Subbiah, Sarah Cannon Research Institute
Robin Yabroff, American Cancer Society
Speakers and Moderators
Alex Adjei, Cleveland Clinic
Catherine Alfano, Northwell Health
Justin Bekelman, Unversity of Pennsylvania
Vishal Bhatnagar, FDA Oncology Center of Excellence
Fumiko Chino, Memorial Sloan-Kettering Cancer Center
Natalie Dickson, TN Oncology
Narjust Florez, Dana-Farber Cancer Institute
Chris Friese, University of Michigan
Shelley Fuld Nasso, National Coalition for Cancer Survivorship
Patricia Ganz, University of California, Los Angeles Jonsson Comprehensive Cancer Center
Julie Gralow, American Society of Clinical Oncology
Sarah Greene, Independent Consultant
Carolyn Hendricks, Maryland Oncology Hematology
Nancy Keating, Dana-Farber Cancer Institute
Heidi Klepin, Wake Forest University
Paul Kluetz, FDA Oncology Center of Excellence
Lucy Langer, United Healthcare
Laura Levit, American Society of Clinical Oncology
Justin List, Veterans Health Administration
Kameron Matthews, Cityblock Health
Robert Miller, ASCO CancerLinQ
Kathi Mooney, University of Utah
Larissa Nekhlyudov, Brigham & Women’s Hospital; Dana-Farber Cancer Institute
Nathan Pennell, Cleveland Clinic
Lori Pierce, University of Michigan
Laurel Pracht, West Valley Ovarian Cancer Alliance
Kate Rendle, University of Pennsylvania
Lisa Richardson, Centers for Disease Control and Prevention
Edmondo Robinson, Moffitt Cancer Center
Julia Rowland, Smith Center for Healing and the Arts
Rebecca Siegel, American Cancer Society
Cardinale Smith, Mount Sinai Health System
Claire Snyder, Johns Hopkins School of Medicine and the PROTEUS Consortium
Patty Spears, Lineberger Comprehensive Care Center; University of North Carolina Chapel Hill
Ishwaria Subbiah, Sarah Cannon Research Institute
Mickey Trockel, Stanford University
Karen Winkfield, Meharry-Vanderbilt Alliance
Rob Winn, National Cancer Policy Forum and Virginia Commonwealth University
Robin Yabroff, American Cancer Society
Robin Zon, American Society of Clinical Oncology